Miami, Florida — Global Stem Cells Group (GSCG), together with the International Society for Stem Cell Application (ISSCA), is pleased to share the success of the recent International Regenerative Medicine Conference, held on March 7 and 8 at the luxurious Secrets The Vine Cancún, located in the heart of the Hotel Zone in Cancún, Mexico.
This two-day event brought together a distinguished lineup of internationally recognized experts in regenerative medicine and biotechnology, offering physicians a unique combination of theoretical lectures and hands-on training sessions. The conference welcomed participants from over 14 countries including the United States, Dominican Republic, Colombia, El Salvador, Puerto Rico, Argentina, Ecuador, Costa Rica, Peru, Bolivia, Honduras, and Panama.
The March 7 segment focused on the theoretical foundations of regenerative medicine, featuring lectures by global leaders in the field. Among the featured speakers:
- Rafael González, Ph.D. (USA), presented a scientific review on Natural Killer Cells.
- Dr. Matt Halpert, Ph.D. (USA) shared insights on Dendritic Cells in the treatment of cancerous tumors.
- Mercedes Kweh, Ph.D. and Frederick Kweh, Ph.D. (USA) addressed key considerations in Exosomes and Secretome Therapeutics.
- Dr. Iván Ibáñez (Spain) explored the frontiers of Biohacking, Metabolism, and Lipedema.
- Dr. Andrea Lapeire (Argentina), Dr. Julio Ferreira (Argentina), Dr. Mario Ojeda (Chile), and Dr. Martín Estévez (Argentina) offered valuable clinical perspectives across various regenerative medicine applications.
These were just some of the many international experts who shared their insights during the day. The program featured a diverse group of speakers from different parts of the world, contributing to a truly global exchange of knowledge and innovation.
The day concluded with an interactive Q&A session and a special Social MedConnect experience at Coco Bongo, a well-known nightclub and entertainment venue in the area, providing attendees and speakers with an engaging evening of networking and entertainment.
On March 8, the focus shifted to hands-on training, with three fully booked parallel tracks conducted across Cellular Hope Institute, Immunocine, and ReHealth facilities in Cancún.
These included:
- Advanced Aesthetic Regenerative Medicine, led by Dr. Andrea Lapeyre and Dr. Julio Ferreira, covered the use of exosomes, allogeneic fibroblasts, autologous and allogeneic stem cells, peptides, and advanced aesthetic protocols.
- Advanced Cellular Therapy, with sessions hosted at Cellular Hope Institute, ImmunoSynth, and ReHealth, featured in-depth modules on Dendritic Cells, Natural Killer Cells, and Exosomes, led by experts including Dr. Matt Halpert, Dr. Rafael González, Dr. Frederick Kweh, and Dr. Mercedes Kweh.
- A third track, led by Dr. Iván Ibáñez, offered a specialized look into Biohacking, Peptides, Obesity, and Metabolism.
Benito Novas, Founder of ISSCA and CEO of Global Stem Cells Group, emphasized ISSCA’s mission, stating:
“We believe that by creating platforms for international collaboration and education, we are helping physicians around the world access the latest advancements in regenerative medicine. Our mission is to foster a global standard of care through training, innovation, and scientific exchange.”
With the conference fully booked and hands-on courses filled to capacity, GSCG and ISSCA extend their sincere thanks to all attendees, speakers, and collaborators who made this event a remarkable experience.
We expect that future editions will continue to build on this momentum, further expanding access to the latest tools and protocols in regenerative medicine across the globe.
For more information about upcoming conferences and certification programs, please visit www.issca.com.
About Benito Novas
Benito Novas is a global entrepreneur and a leading figure in regenerative medicine, Founder of International Society for Stem Cell Application(ISSCA) and CEO of Global Stem Cells Group. He has been instrumental in expanding the reach of regenerative therapies worldwide, helping thousands of physicians integrate stem cell treatments into their practices through training programs and strategic support. Under Novas’s leadership, access to regenerative medicine education and technology has grown exponentially across the globe, solidifying his reputation as a key innovator in the field.
About the International Society for Stem Cell Application (ISSCA)
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary global network of physicians and scientists committed to the advancement of regenerative medicine and stem cell-based therapies. ISSCA’s mission is to lead in certification, education, research, and training, promoting high standards and best practices in the field. With members in over 35 countries, the organization fosters collaboration and knowledge-sharing to support the safe and effective implementation of cutting-edge cellular treatments in clinical practice.
About Global Stem Cells Group (GSCG)
Global Stem Cells Group (GSCG) is an international consortium dedicated to stem cell research, clinical applications, and physician education. The organization brings together several specialized companies under one umbrella to offer innovative patient treatment protocols, hands-on training programs, and regulatory consulting. GSCG is committed to expanding access to regenerative medicine worldwide and supports physicians through certification programs, conferences, and scientific collaboration.
Global Stem Cells Group is a publicly traded company operating under the symbol RMTG. https://finance.yahoo.com/quote/RMTG/
To learn more about Global Stem Cells Group, Inc.’s companies, visit our website www.stemcellsgroup.com or call +1 305 560 5331.
About ReHealth
ReHealth is a premier regenerative medicine center based in Cancún, Mexico, recognized for its expertise in stem cell therapy, natural killer (NK) cell treatments, and exosome-based protocols. The clinic offers personalized therapeutic solutions backed by years of research and clinical development. With a state-of-the-art laboratory and treatment facility that adheres to international quality standards, ReHealth provides advanced regenerative care in a safe, patient-centered environment, attracting patients from around the world.
About Immunocine
Immunocine Cancer Center is a cutting-edge medical institution in Cancún specializing in advanced cancer immunotherapy. Led by Dr. Matthew Halpert, the center has developed a novel dendritic cell therapy that reprograms the patient’s immune cells to recognize and attack cancer without the use of foreign drugs or genetic modification. This proprietary approach is currently undergoing clinical evaluation and has shown promising results in treating challenging cancers. ImmunoCine continues to push the boundaries of immune-based regenerative treatments.
Safe Harbor Statement: Statements in this news release may be “forward-looking statements”. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
